Trial · NCT05816720
Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
NCT05816720, Completed, Novartis Pharmaceuticals
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®). Trials, record NCT05816720. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05816720
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
- NCT number
- NCT05816720
- Status
- Completed
- Enrollment
- 31 participants, actual
- Lead sponsor
- Novartis Pharmaceuticals
- Conditions
- Neuroendocrine Tumor
- Interventions
- Lutetium-177 DOTATATE
- First posted
- 2023-04-18
- Last updated
- 2023-04-18
Source ClinicalTrials.gov
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression-free survival | Up to approximately 11 years | Time from the index date of treatment or re-treatment with lutetium-177 DOTATATE until the date of progression or death |
| Primary | Overall survival | Up to approximately 11 years | Time from the index date of treatment or re-treatment with lutetium-177 DOTATATE until the date of death |
| Primary | Percentage of patients with treatment response | Up to approximately 11 years | Best overall response was defined per Response Evaluation Criteria In Solid Tumors (RECIST), 1.1. Overall response: complete response (CR) + partial response (PR); CR; PR; stable disease (SD); and progressive disease (PD) |
| Secondary | Number of patients with adverse events (AEs) | Up to approximately 11 years | |
| Secondary | Mean change from baseline in white blood cell (WBC) count | Up to approximately 11 years | |
| Secondary | Mean change from baseline in hemoglobin | Up to approximately 11 years | |
| Secondary | Mean change from baseline in absolute neutrophil count (ANC) | Up to approximately 11 years | |
| Secondary | Mean change from baseline in lymphocyte count | Up to approximately 11 years | |
| Secondary | Mean change from baseline in platelet count | Up to approximately 11 years | |
| Secondary | Mean change from baseline in alkaline phosphatase (ALP) | Up to approximately 11 years |
1 to 10 of 23Source ClinicalTrials.gov
See all 23 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05816720
GET https://conductscience.org/api/trials/v1/NCT05816720/registered?page=2